CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Progenity Receives New Patent for Their Single-Molecule Detection Platform

Life Sciences Review Life Sciences Review | Friday, December 17, 2021
Tweet

Progenity has received a US patent for their Single-Molecule Detection Technology, which will lower testing and treatment costs while also simplifying operational implementation.


Fremont, CA: Single molecule detection methods discover individual molecular properties and their environment. Single-molecule imaging has caught researchers' attention in a variety of fields because it allows them to examine molecular features that are generally hidden in big molecular groups. Progenity, Inc., a biotechnology firm focused on gastrointestinal health and oral biotherapeutics, has received a new patent for their single-molecule detection platform, which is currently in development.


The United States Patent and Trademark Office (USPTO) has issued US Patent No. 11,186,863 for Methods, Systems, and Compositions for Counting Nucleic Acid Molecules. Methods for capturing, amplifying, and imaging single copies of target nucleic acid molecules are covered by the issued claims.


According to Matthew Cooper, General Manager, Diagnostics, "This invention includes important methods for counting target molecules, obviating the requirement for sequencing."


Our Single-Molecule Detection Platform is meant to allow procedures like noninvasive prenatal testing (NIPT) or liquid biopsy for cancer to be performed without the use of expensive, sophisticated sequencing, lowering costs and simplifying operations. Beyond nucleic acids, the technology has the potential to be used with proteins. Progenity is actively seeking partners to further develop this valuable asset as it transitions away from commercial diagnostics.


Progenity has built a strong patent portfolio to support its single-molecule detection platform, which includes six patent families covering various aspects of the company's molecular counting platform, as well as a separate family, focused on detecting nucleosomal positioning patterns, which can be useful for determining cell-free DNA tissue-of-origin. These patents are part of Progenity's corporate portfolio, which includes 96 patent families with 180 issued patents and over 220 patent applications pending. The portfolio includes patents and applications for medication administration methods and devices, GI sampling and diagnostics methods and devices, illness treatment methods and compositions, and molecular and protein tools, assays, and diagnostics.


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/progenity-receives-new-patent-for-their-singlemolecule-detection-platform-nwid-668.html